Adagio Medical announced the completion of its business combination with ARYA IV, resulting in the creation of a publicly traded company focused on innovative technologies for the treatment of cardiac arrhythmias. The business combination was approved by the shareholders and the combined company raised approximately $84.2 million in financing.
Company Information
Company
Adagio Medical
Location
26051 MERIT CIRCLE
Laguna Hills, California, United States
About
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias utilizing its novel, proprietary, catheter-based Ultra-Low Temperature Cryoablation (ULTC) technology. ULTC is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The Company is currently focused on the treatment of ventricular tachycardia (VT) with its purpose-built vCLASTM Cryoablation System which is CE Marked and is currently under evaluation in the Company’s FULCRUM-VT U.S. IDE Pivotal Study.
Laguna HillsBiotechnologyHealthcareHealth CareMedicalMedical Device